Ocumension Therapeutics (1477) Financial Statements

1 Followers

Ocumension Therapeutics Financial Overview

Ocumension Therapeutics's market cap is currently HK$6.03B. The company's EPS TTM is HK$-0.0453576452; its P/E ratio is -34.12; Ocumension Therapeutics is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is HK$-0.03. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 783.53M	¥ 417.31M	¥ 246.37M	¥ 158.96M	¥ 56.15M
Gross Profit	¥ 343.08M	¥ 225.06M	¥ 144.37M	¥ 102.92M	¥ 36.94M
Operating Income	¥ -156.06M	¥ -306.43M	¥ -402.15M	¥ -455.86M	¥ -385.20M
EBITDA	¥ -147.56M	¥ -188.03M	¥ -320.62M	¥ -359.98M	¥ -249.81M
Net Income	¥ -154.71M	¥ -268.27M	¥ -379.79M	¥ -402.64M	¥ -259.99M
Balance Sheet
Cash & Short-Term Investments	¥ 402.63M	¥ 769.21M	¥ 1.05B	¥ 1.29B	¥ 1.77B
Total Assets	¥ 4.09B	¥ 3.97B	¥ 3.27B	¥ 3.04B	¥ 3.33B
Total Debt	¥ 187.62M	¥ 25.78M	¥ 137.98M	¥ 29.58M	¥ 11.21M
Net Debt	¥ -215.02M	¥ -703.42M	¥ -704.86M	¥ -1.14B	¥ -1.11B
Total Liabilities	¥ 410.38M	¥ 200.19M	¥ 351.03M	¥ 295.04M	¥ 222.88M
Stockholders' Equity	¥ 3.68B	¥ 3.77B	¥ 2.92B	¥ 2.75B	¥ 3.11B
Cash Flow
Free Cash Flow	¥ -358.65M	¥ -408.97M	¥ -539.79M	¥ -510.66M	¥ -861.66M
Operating Cash Flow	¥ -105.29M	¥ -178.83M	¥ -177.93M	¥ -200.66M	¥ -196.85M
Investing Cash Flow	¥ -361.46M	¥ 275.91M	¥ -259.78M	¥ 229.15M	¥ -1.35B
Financing Cash Flow	¥ 118.04M	¥ -213.79M	¥ 108.66M	¥ -9.22M	¥ 668.85M

Currency in CNY

Ocumension Therapeutics Earnings and Revenue History

Income Statement >

Ocumension Therapeutics Debt to Assets

Balance Sheet >

Ocumension Therapeutics Cash Flow

Cash Flow >

Ocumension Therapeutics Forecast EPS vs Actual EPS

Earnings >